Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 125: 1069-1074, 2019 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-30552929

RESUMO

Thymol is a natural bioactive agent which possesses various medicinal properties like antimicrobial, antifungal, anti-inflammatory, anticancer etc. and has been widely used in traditional medicine and food industries. It is eco-friendly, cheap, nontoxic and has been granted generally recognized as safe (GRAS) notation by USFDA. Its use is somewhat muted due to drawbacks like lesser bioavailability, comparatively poor solubility and low susceptibility to oxidation. In the present work, nanoformulation of thymol was prepared by ionic complexation of tragacanth gum and chitosan. Chitosan of different concentrations was used to obtain desired particle size and encapsulation efficiency. It was noted that a ratio of 1:2 (tragacanth gum:chitosan) yielded a minimum particle size along with higher encapsulation efficiency. Morphology of these optimized nanoparticles was found to be spherical using TEM. These particles were found in the size range of 150-200 nm. Further comparative study of the prepared nanoformulation and thymol for antioxidant and anti-inflammatory efficacy was done using DPPH method and HRBC (Human red blood cell) stabilization method. The results suggested an increase in both anti-inflammatory and antioxidant activity of thymol nanoformulation. This study will open up new avenues for application in the field of food and pharmaceutical industries.


Assuntos
Anti-Inflamatórios/farmacologia , Antioxidantes/farmacologia , Quitosana/química , Preparações de Ação Retardada/farmacologia , Nanopartículas/química , Timol/farmacologia , Tragacanto/química , Anti-Inflamatórios/química , Antioxidantes/química , Compostos de Bifenilo/antagonistas & inibidores , Preparações de Ação Retardada/química , Diclofenaco/farmacologia , Portadores de Fármacos , Composição de Medicamentos/métodos , Liberação Controlada de Fármacos , Eritrócitos/efeitos dos fármacos , Humanos , Cinética , Nanopartículas/ultraestrutura , Tamanho da Partícula , Picratos/antagonistas & inibidores , Timol/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...